Results 261 to 270 of about 2,664,817 (408)
Wearable Bioelectronics for Home‐Based Monitoring and Treatment of Muscle Atrophy
As an inevitable disease, muscle atrophy has received more attention. Because the factors that induce this disease are diverse, achieving a complete cure is still impossible. Wearable bioelectronics provides a more comfortable, low‐cost, and efficient way of home care for the monitoring and treatment of muscle atrophy. Therefore, this review summarizes
Shuai Zhang+4 more
wiley +1 more source
Association of liver biopsy pathology on outcome of patients undergoing heart transplantation. [PDF]
Eichenwald LS+6 more
europepmc +1 more source
A study of liver biopsies and liver disease among hemophiliacs [PDF]
LM Aledort+9 more
openalex +1 more source
Pathologic observations in human allograft recipients treated with FK 506 [PDF]
Banner, B+6 more
core
This study integrates scRNA‐seq, multiplex immunofluorescence, and clinical data to identify HLA‐DR⁺tumor cells uniquely enriched in Hepatocellular carcinoma (HCC) with hepatitis B virus (HBV). These cells express MHC II, associate with PD‐L1, recruit and exhaust CD8⁺T cells, predict poor survival, and serve as potential biomarkers for immunotherapy ...
Jun‐Qing Chang+17 more
wiley +1 more source
Should Liver Scan be a Prerequisite to Liver Biopsy?
Andrew B. Lipton, C. Michael Knauer
openalex +1 more source
The Multitarget Compound ZLY032 Achieves Treatment of Chronic Wounds
ZLY032, a dual free fatty acid receptor 1/peroxisome proliferator‐activated receptor δ agonist, accelerates wound healing in normal/diabetic/methicillin‐resistant Staphylococcus aureus‐infected models by promoting angiogenesis, reducing inflammation, and exhibiting antibacterial activity via argininosuccinate lyase targeting, with demonstrated efficacy
Manyu Gong+27 more
wiley +1 more source
Traumatic Cystic Artery Pseudoaneurysm After Transjugular Liver Biopsy: A Case Report. [PDF]
Bezold A+4 more
europepmc +1 more source
The study innovatively integrates single‐cell electric impedance identification and drug screening on a semiconductor chip, addressing tumor heterogeneity limitations. The system achieves label‐free cancer cell recognition while concurrently evaluating drug efficacy on cancer cells and toxicity on noncancerous cells.
Wenhao Hui+13 more
wiley +1 more source